Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer and Biohaven close collaboration agreements
Pfizer has completed the collaboration transaction with Biohaven Pharmaceuticals to obtain rights to market the latter’s rimegepant and zavegepant outside of the US.
Drug Manufacturing
-
06 Jan 2022
-
04 Jan 2022
Ovid signs license deal with AstraZeneca to expand epilepsy drug pipeline
Ovid Therapeutics has signed a license agreement with AstraZeneca for a library of early-stage small molecules that target the KCC2 transporter.
-
03 Jan 2022
Ascletis expands ritonavir oral tablets production amid Covid-19 surge
Ascletis Pharma is expanding the production of ritonavir oral tablets as well as the oral direct-acting antiviral R&D pipeline to treat SARS-CoV-2 virus amid the recent surge in Covid-19 cases.
-
29 Dec 2021
Texas Children’s Hospital to launch protein sub-unit Covid-19 vaccine
Texas Children's Hospital and Baylor College of Medicine are set to launch Corbevax, a protein sub-unit Covid-19 vaccine in India, with plans to roll out in other underserved countries later.
-
23 Dec 2021
Pfizer to deliver 2.5 million additional doses of Covid-19 pill to UK
Pfizer has signed an agreement to deliver an additional 2.5 million treatment courses of its investigational Covid-19 pill Paxlovid to the UK.
-
14 Dec 2021
Novo Nordisk to invest in new production facilities at Danish plant
Novo Nordisk has announced plans to make more than $2.58bn (DKK17bn) investment to expand its manufacturing facilities in Kalundborg, Denmark.
-
30 Nov 2021
Valneva, IDT Biologika partner to produce Covid-19 vaccines
French company Valneva and IDT Biologika have partnered to manufacture the former’s inactivated vaccine candidate, VLA2001, for Covid-19.
-
14 Sep 2021
AzurRx to acquire First Wave Bio for $229m
US-based biopharmaceutical firm AzurRx BioPharma has agreed to acquire clinical-stage biotechnology company First Wave Bio in a stock-and-cash deal valued at $229m.
-
11 Aug 2021
Moderna to build new mRNA vaccine manufacturing facility in Canada
Biotechnology firm Moderna and Canadian government have signed a memorandum of understanding (MoU) to construct a new messenger RNA (mRNA) vaccine manufacturing facility in Canada.
-
04 Aug 2021
Amgen to construct new drug substance manufacturing plant in North Carolina
Amgen has announced plans to construct a new multi-product drug substance manufacturing facility in Holly Springs, North Carolina, the US.